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Bone Microenvironment Specific Roles of ITAM Adapter
Signaling during Bone Remodeling Induced by Acute
Estrogen-Deficiency
Yalei Wu1,2, James Torchia1, Wei Yao3, Nancy E. Lane3, Lewis L. Lanier2,4, Mary C. Nakamura1, Mary Beth Humphrey5*
1Department of Medicine, VA Medical Center, University of California San Francisco, San Francisco, California, United States of America, 2Department
of Microbiology and Immunology, University of California San Francisco, San Francisco, California, United States of America, 3Department of
Medicine, University of California Davis, Sacramento, California, United States of America, 4Cancer Research Institute, University of California San
Francisco, San Francisco, California, United States of America, 5Department of Medicine and Microbiology and Immunology, VA Medical Center and
University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, United States of America
Immunoreceptor tyrosine-based activation motif (ITAM) signaling mediated by DAP12 or Fce receptor Ic chain (FcRc) have been
shown to be critical for osteoclast differentiation and maturation under normal physiological conditions. Their function in
pathological conditions is unknown. We studied the role of ITAM signaling during rapid bone remodeling induced by acute
estrogen-deficiency in wild-type (WT), DAP12-deficient (DAP12-/-), FcRc-deficient (FcRc-/-) and double-deficient (DAP12-/-
FcRc-/-) mice. Six weeks after ovariectomy (OVX), DAP12-/-FcRc-/- mice showed resistance to lumbar vertebral body (LVB)
trabecular bone loss, while WT, DAP12-/- and FcRc-/- mice had significant LVB bone loss. In contrast, all ITAM adapter-deficient
mice responded to OVX with bone loss in both femur and tibia of approximately 40%, relative to basal bone volumes. Only WT
mice developed significant cortical bone loss after OVX. In vitro studies showed microenvironmental changes induced by OVX
are indispensable for enhanced osteoclast formation and function. Cytokine changes, including TGFb and TNFa, were able to
induce osteoclastogenesis independent of RANKL in BMMs from WT but not DAP12-/- and DAP12-/-FcRc-/- mice. FSH
stimulated RANKL-induced osteoclast differentiation from BMMs in WT, but not DAP12-/- and DAP12-/-FcRc-/- mice. Our study
demonstrates that although ITAM adapter signaling is critical for normal bone remodeling, estrogen-deficiency induces an
ITAM adapter-independent bypass mechanism allowing for enhanced osteoclastogenesis and activation in specific bony
microenvironments.
Citation: Wu Y, Torchia J, Yao W, Lane NE, Lanier LL, et al (2007) Bone Microenvironment Specific Roles of ITAM Adapter Signaling during Bone
Remodeling Induced by Acute Estrogen-Deficiency. PLoS ONE 2(7): e586. doi:10.1371/journal.pone.0000586
INTRODUCTION
The osteoclast is the only bone-resorbing cell, and it develops from
myeloid lineage cells, including macrophages and monocytes. It
has been well established that receptor activator for nuclear factor
k B ligand (RANKL, also known as TRANCE, ODF, OPGL, and
TNFSF11) and macrophage colony-stimulating factor (M-CSF)
are required during osteoclast differentiation. Recent evidence
suggests that immunoreceptor tyrosine-based activation motif
(ITAM) containing adapter proteins, DAP12 or Fce receptor I c
chain (FcRc), are critical for osteoclast maturation and function
under normal physiologic conditions in vivo and in vitro [1–4]. Upon
activation, the tyrosines in the ITAM, YxxL/Ix6-8YxxL/I (where
x represents any amino acid), are phosphorylated by members of
the Src kinase family. The tyrosine kinase Syk is then recruited to
initiate a signal transduction cascade, which includes phospholi-
pase Cc (PLCc), calcium mobilization, phosphatidylinositol-3
kinase (PI3K), Ras, nuclear factor-kB (NFkB), and nuclear factor
for activation of T cells (NFAT).
With minimal extracellular domains, DAP12 and FcRc have no
known ability to bind ligands. Therefore, they are insufficient to
sense the local microenvironment alone. The DAP12 and FcRc
signaling adapters associate with innate immune transmembrane
receptors that have ligand recognition domains. Innate immune
receptors are genetically encoded to sense environmental changes
and provide front line defense against infection. Certain activating
innate immune receptors, such as Dectin-1 [5], use intrinsic
ITAMs to transduce activating signals [1]; however, there is also
a class of innate immune receptors that lack signaling motifs in
their intracellular domains. Instead, these receptors with minimal
cytoplasmic domains partner with ITAM-containing adapter
proteins, like DAP12 or FcRc, and form protein complexes to
mediate their downstream signals [3,6]. ITAM-bearing adapter-
associated receptors expressed in preosteoclasts or osteoclasts
include triggering receptor expressed on myeloid cells (TREM2),
osteoclast-specific activating receptor (OSCAR), myeloid DAP12-
associating lectin-1 (MDL-1), signal regulatory protein-b (SIRPb),
and paired-Ig-like receptor-a (PIRa) [1]. Depending on the
structural properties of their transmembrane regions, these
receptors will associate with either DAP12 or FcRc to transduce
downstream signals. Mice that are doubly deficient in both
adapter proteins, DAP12 and FcRc, have severe osteopetrosis with
a trabecular bone volume/tissue volume (BV/TV) around 60%
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and single nucleated osteoclasts both in vitro and in vivo [4]. Mice
that are deficient in a single adapter protein, either DAP12 or
FcRc, have moderate or mild osteopetrosis, respectively. These
data indicate that ITAM signaling mediated by these distinct
groups of receptor-adapter protein complexes can compensate
partially for each other. Poorly functional osteoclasts in double-
deficient mice suggest that ITAM-containing adapter-associated
receptors and their ligands present in the microenvironment are
critical for osteoclast differentiation in normal bone remodeling.
Specific ligands that activate ITAM signals in osteoclast
precursors have not been identified. It is also unknown whether
ligands in the bone microenvironment are subjected to change in
different physiological conditions. The mouse ovariectomy (OVX)
model has been a useful tool to study rapid bone remodeling,
induced by estrogen-deficiency that proceeds after bilateral
oophorectomy. During OVX-induced bone loss, several genes
have been identified to be essential in osteoclastogenesis, including
b3 integrin, MIF, IGF-I, thrombospondin-2 and PAI-1. The
deficiency of these genes has been shown to protect mice from
bone loss in OVX studies [7–11]; however, the role of ITAM
signaling in bone remodeling during estrogen-deficiency has not
been addressed.
Using the OVX model in mice that are deficient for either one
or both ITAM-containing adapter proteins, we examined whether
acute estrogen-deficiency would increase bone remodeling at
several bone locations. In addition, we examined the role of ITAM
signaling during osteoclast differentiation and functional changes
after OVX in vivo and in vitro.
RESULTS
Estrogen-deficiency induces bone remodeling in
ITAM-adapter deficient mice
In this study, we used the ovariectomy model to study the
physiological role of ITAM signaling in estrogen-deficiency-
induced bone remodeling. Eight-week-old female mice underwent
sham operation (SHAM) or bilateral ovariectomy (OVX), and
bone remodeling was evaluated at 6 weeks post-procedure. At the
time of sacrifice, uterine atrophy confirmed successful ovariectomy
in all four OVX groups (Fig. 1A). At 4 weeks after operation, urine
and blood samples were collected to evaluate bone remodeling,
using serum osteocalcin, a bone formation marker, and urinary
deoxypyridinoline (DPD), a bone resorption marker. Serum
osteocalcin was increased in the OVX group of WT and
DAP12-/- mice compared to their SHAM groups. Osteocalcin
remained unchanged in the FcRc-/- and DAP12-/-FcRc-/- OVX
mice (Fig. 1C). Urinary DPD was lower at basal level in both
DAP12-/- and DAP12-/-FcRc-/- SHAM mice compared to WT
and FcRc-/- SHAM groups, indicating abnormal osteoclast
function at baseline (Fig. 1B). Urine DPD level was increased in
all OVX groups independent of ITAM status, indicating in-
creasing bone resorption.
Estrogen-deficiency induces site-specific bone loss
in ITAM adapter-deficient mice
MicroCT (mCT) of the trabecular region of lumbar vertebral body
(LVB) at 6 weeks post-OVX was performed to determine the bone
microarchitecture and bone mass (bone volume/ tissue volume;
BV/TV). OVX induced significant bone loss in LVB of WT and
FcRc-/- mice. DAP12-/- mice had a baseline BV/TV of
approximately 30% at the LVB, a doubling of bone mass
compared to WT mice (p,0.001). Although DAP12-/- mice
exhibited bone loss (5% of BV/TV) at this site, the bone mass
remained significantly higher compared to SHAM WT (p,0.01).
No significant bone loss occurred in the DAP12-/-FcRc-/- OVX
group (BV/TV=50%) compared to SHAM (BV/TV=51%)
(Fig. 2A).
The microarchitectural analysis results of the mCT were
consistent with the bone mass analysis. Both DAP12-/- and
DAP12-/-FcRc-/- SHAM groups had thicker trabeculae com-
pared to WT and FcRc-/- mice (Fig. 2B). 6 weeks post-OVX, WT,
DAP12-/-, and FcRc-/-mice had statistical significant decreases in
the trabecular thickness (Fig. 2B). Notably, DAP12-/- and
DAP12-/-FcRc-/- mice had higher trabecular numbers compared
to WT and FcRc-/- mice (Fig. 2C). In all four groups of mice, only
the DAP12-/- OVX group showed a statistically significant
reduction in trabecular number. However, thinning of trabeculae
and reduction in trabecular counts were not observed in the
DAP12-/-FcRc-/- OVX group compared to SHAM. These data
suggest that ITAM adapter signaling is required for estrogen
deficiency-related bone loss in the vertebrae, and the expression of
either DAP12 or FcRc ITAM adapter is sufficient to mediate bone
remodeling signals in vertebrae after OVX.
Cortical bone remodeling has been demonstrated to respond to
estrogen-deficiency in mice. Therefore, we determined whether
ITAM-adapter signaling is required during this process. We
analyzed cortical bone proximal to the tibiofibular joint by mCT.
As shown in Fig. 2D, a statistically significant decrease in cortical
thickness was only observed in WT OVX mice. DAP12-/- and
FcRc-/- mice showed a trend toward a decrease of trabecular
thickness in OVX group, but didn’t reach statistical significance at
6 weeks post-procedure. DAP12-/-FcRc-/- mice had the thickest
cortical bones and exhibited no change post-OVX. Thus, as in
lumbar vertebrae, ITAM-adapter signaling is required for cortical
bone loss induced by acute estrogen-deficiency.
Estrogen-deficiency induced trabecular bone loss in
long bones is ITAM-adapter independent
MicroCT evaluation of the distal femur and proximal tibia was
performed at 6 weeks post-OVX or SHAM operations. Unlike the
vertebrae and cortical bone, significant trabecular bone loss was
observed in all ITAM-adapter deficient mice following OVX
(Fig. 3A). The 3-D reconstructed mCT images of trabeculae in
distal femur from both SHAM (Fig. 3A, upper panel) and OVX
(Fig. 3A, lower panel) exhibited loss of trabecular bone in mice
independent of ITAM-adapter status. Although all four mouse
groups showed reductions in trabecular bone mass following OVX
operation, DAP12-/-FcRc-/- mice had the most significant
change, as their trabecular bone changed from a more solid struc-
ture with few holes to a very porous sponge-like structure (Fig 3A).
BV/TV dropped significantly in WT from 5.7% to 2.9%, a 49%
relative bone loss (Fig. 3B, Table 1). DAP12-/- mice showed a 41%
relative trabecular bone loss (BV/TV dropping from 20.6% to
12.1%). A similar 38% relative bone loss was observed in DAP12-/-
FcRc-/- OVX group (BV/TV dropping from 56.2% to 35%)
(Fig. 3A, Table 1). FcRc-/- mice also showed similar relative bone
loss of 43%, although the bone loss didn’t reach a statistical
significance (p= 0.09) (Fig. 3B, Table 1). The biggest decrease of
BV/TV was seen in DAP12-/-FcRc-/- mice, 21.3% compared to
2.8% in WT, 8.4% in DAP12-/- and 5% in FcRc-/- mice.
Mean density of the trabecular region (Fig. 3C) showed strong
correlation with BV/TV (Fig. 3B), whereas the mean density of
trabeculae stayed constant in both groups from all four different
mice (Fig. 3D), indicating the bone loss was due to structural
destruction of trabeculae. mCT-based structural analysis showed
similar findings. Consistent with dysfunctional osteoclasts under
Roles of ITAM Signaling in OVX
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normal bone remodeling conditions, DAP12-/-FcRc-/- mice had
the highest trabecular number and thickness in the SHAM group,
followed by DAP12-/- (Fig 3E, 3G). A statistically significant
reduction in trabecular number was seen in all OVX groups at
6 weeks post operation compared to their SHAM groups (Fig. 3E).
Smaller trabecular spacing was also observed in all ITAM-adapter
deficient mice SHAM groups compared to WT SHAM (Fig. 3F).
Among them, DAP12-/-FcRc-/- mice had the smallest spacing,
about 1/3 of WT (Fig. 3F). OVX induced a statistically significant
increase in trabecular spacing in all four OVX groups, including
DAP12-/-FcRc-/- mice (Fig. 3F). OVX induced a decrease in
trabecular thickness in all four OVX groups compared to the
SHAM groups (Fig. 3G). Interestingly, while DAP12-/-FcRc-/-
OVX group still maintained higher trabecular number and
smaller trabecular spacing among all OVX groups (p,0.05), the
difference in trabecular thickness was no longer statistically
significant after OVX (Fig. 3G). Similar bone losses were observed
in the proximal tibia at 6 weeks in all OVX groups (data not
shown). Thus, ITAM-adapter signaling is not required for
estrogen-deficient bone loss in the trabecular rich regions of long
bones, indicating that these bone microenvironments have an
ITAM-adapter independent mechanism to generate active
osteoclasts. Furthermore, mice deficient in DAP12 alone or in
combination with FcRc deficiency had significantly more absolute
bone loss than WT mice, suggesting loss of an inhibitory signal
required to limit bone loss induced by OVX.
Estrogen-deficiency induces an increased number of
multinucleated osteoclasts in DAP12-/-FcRc-/- mice
in vivo
Although DAP12-/-FcRc-/- mice failed to lose trabecular bone in
their vertebrae and cortical areas under estrogen-deficient
conditions, they showed a substantial trabeculae bone loss of
38% in long bones. DAP12-/-FcRc-/- osteoclasts have been shown
to be defective in function both in vivo and in vitro, with
mononuclear osteoclasts having poor bone resorbing ability
[3,4]. To determine the mechanism allowing significantly in-
creased bone remodeling post-OVX in DAP12-/-FcRc-/- mice, we
looked for in vivo evidence of OVX-induced osteoclast generation
or function.
6 weeks post-operations, femurs from DAP12-/-FcRc-/- mice
were processed for histological examination. Consistent with the
mCT analysis, the bone marrow cavities were small in the SHAM
group (Fig. 4A, upper panel), compared to the OVX group
(Fig. 4A, lower panel). In the DAP12-/-FcRc-/- SHAM group,
mononucleated TRACP-positive osteoclasts were identified (in-
dicated by purple arrows in Fig. 4A, upper panel), while only a few
multinucleated osteoclasts were identified (data not shown). In the
OVX group, a significant increase in multinucleated osteoclast
number was observed (p= 0.0008) (indicated by red asterisk in
Fig. 4A, lower panel, Fig. 4B). The multinucleated osteoclasts had
increased size and revealed stronger TRACP staining. The
Figure 1. Bone remolding markers and uterine weights. (A) Uterine weight was measured at the end of the experiment when mice were sacrificed.
Four weeks after operations, urine DPD (B) and serum osteocalcin (C) were measured. WT: wild-type mice; DKO: mice lacking both DAP12 and FcRc.
N = 5 in each group. *: p,0.05; **: p,0.01; ***: p,0.001; when compared to SHAM groups, respectively.
doi:10.1371/journal.pone.0000586.g001
Roles of ITAM Signaling in OVX
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mononucleated osteoclast number was also increased in the
DAP12-/-FcRc-/- OVX group, but the difference was not
statistically significant (p = 0.14) (Fig. 4B). Total osteoclast number
was significantly higher in OVX compared to SHAM (Fig. 4B).
Histomorphometry study on lumbar vertebrae from WT,
DAP12-/-, and FcRc-/- mice is consistent with our mCT analysis.
Osteoclast surface and osteoclast surface per bone surface were
increased in DAP12-/- and FcRc-/- OVX mice, reaching
statistical significance in both parameters only in FcRc-/- mice
(p,0.05). Osteoclast number increased 50% in DAP12-/- OVX
(p= 0.28) and 80% in FcRc-/- OVX (p= 0.063) groups.
Mineralizing surface was decreased 25% in DAP12-/- OVX mice
(p = 0.07) and was increased 51% in FcRc-/- OVX mice
(p = 0.15), indicating a differential bone formation response in
ITAM-adapter deficient mice. These data are consistent with an
ITAM-adapter independent increase in osteoclast number and
activity as the main mechanism behind the acute estrogen-
deficient bone loss observed in ITAM-adapter deficient mice.
Increased osteoclast function induced by OVX is not
sustained in vitro from DAP12-/- and DAP12-/-
FcRc-/- mice
An increased number of multinucleated osteoclasts in vivo in
DAP12-/-FcRc-/- mice post-OVX indicates that the requirement
for ITAM-adapter costimulation may be bypassed during
estrogen-deficiency. To investigate if this compensatory mecha-
nism is intrinsic to the osteoclast progenitor lineage, we analyzed in
vitro osteoclast differentiation and function post-OVX. In order to
recapitulate the increased osteoclast function in vitro, we cultured
preosteoclasts from bone marrow-derived macrophages (BMM)
from both OVX and SHAM groups, seeded them on an artificial
calcium-phosphate substrate (BD BioCoat), and measured re-
sorption. Preosteoclasts were cultured with M-CSF and RANKL
for 7 days. Resorption areas were visualized with microscopy and
digital images captured (Fig. 5A). As expected, in vitro cultured
osteoclasts from the WT OVX group had increased number and
size of resorption pits and the total resorption area was
significantly increased (about 2-fold) compared to the WT SHAM
group (Fig. 5B, 5C). Similar to WT, osteoclast cultures from
FcRc-/- OVX showed a significant increase in resorption pit
number and total resorption area compared to FcRc-/- SHAM
(Fig. 5B, 5C). Interestingly unlike WT and FcRc-/- mice,
osteoclast cultures from DAP12-/- and DAP12-/-FcRc-/- mice
did not show an increase in resorption area in the resorption assay
(Fig. 5A, 5B, 5C). Therefore, the osteoclast cultures from WT and
FcRc-/- mice could sustain the stimulatory signaling of estrogen-
deficiency in the in vitro culture; whereas DAP12-/- and DAP12-/-
FcRc-/- in vitro derived osteoclasts had no increase in in vitro
resorption capacity post-OVX. Co-culture of stromal cells and
BMMs from DAP12-/- and DAP12-/-FcRc-/- OVX groups failed
to rescue enhanced osteoclast generation or function (data not
shown). These results indicate that the increase in osteoclast
number and size in vivo is not due to an osteoclast intrinsic change
Figure 2. OVX-induced bone remodeling in lumbar vertebra and cortical bone. Six weeks after operations, the sixth lumbar vertebra (LVB6), and
tibia were processed and analyzed by mCT, as described in Materials and Methods. Trabecular bone volume/tissue volume (A), trabecular thickness
(B), and trabecular number (C) of LVB6, and cortical thickness of tibia at distal tibiofibular junction (D) are shown. WT: wild-type mice; DKO: mice
lacking both DAP12 and FcRc. N = 5 in each group. *: p,0.05; **: p,0.01; ***: p,0.001; when compared to SHAM groups, respectively.
doi:10.1371/journal.pone.0000586.g002
Roles of ITAM Signaling in OVX
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but to a microenvironmental change permissive to ITAM-adapter
independent osteoclastogenesis.
TNFa stimulation fails to rescue ITAM-adapter
deficient osteoclast defects
The essential role of RANKL during osteoclastogenesis was
challenged by Kim et al. [12] when they demonstrated that
osteoclast differentiation in vitro could be induced by TNF-
a independent of the RANK-TRAF6 axis. Their data suggested
alternative routes for osteoclast differentiation. It’s known that
estrogen-deficiency can induce systemic cytokine changes (such as
TNFa, IL6, IL1, IL7, and M-CSF) [13,14] and in the bone
resorbing lacunae. In order to determine a possible mechanism for
ITAM-adapter independent osteoclastogenesis induced by OVX,
we examined the effect of cytokine stimulation on osteoclast
differentiation with ITAM-adapter signaling deficiency. BMM
from WT, DAP12-/-, and DAP12-/-FcRc-/- mice were treated
with TGFb for two days, followed by TNFa or RANKL
stimulation. As shown in Fig. 6, TGFb treatment alone failed to
induce any TRACP activity in all groups, as indicated by the lack
of TRACP+-staining cells (Fig. 6B, 6F, 6J). TGFb treatment also
potentiated the effect of RANKL in wild-type osteoclast cultures,
forming large, more complex multinucleated cells (Fig. 6D, 6H,
6L) compared to RANKL treatment alone (Fig. 6A, 6E, 6I).
Additionally, in the absence of RANKL, TNFa following TGFb
treatment effectively induced multinucleated TRACP+ osteoclast
formation in WT BMM. RANKL-treated BMMs from DAP12-/-
Figure 3. OVX-induced bone remodeling of trabeculae in distal femur. Six weeks after operations, femurs were processed and analyzed by mCT.
Representative figures of 3D reconstructed mCT results are shown in (A), with average BV/TV indicated below. Trabecular BV/TV (B); mean bone
mineral density of TV (C); mean bone mineral density of trabeculae (D); trabecular number (E); trabecular spacing (F) and trabecular thickness (G) are
shown. Scale bar in (A) shows 1 mm physical size. WT: wild-type mice; DKO: mice lacking both DAP12 and FcRc. N = 5 in each group. *: p,0.05; **:
p,0.01; ***: p,0.001; when compared to SHAM groups, respectively. ** in (G) indicates p,0.01 when DKO sham group were compared to sham
group of all three other mice. N= 5 for each group.
doi:10.1371/journal.pone.0000586.g003
Table 1. Bone loss in the trabecular region of the distal femur.
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WT DAP12-/- FcRc-/- DKO
BV/TVSHAM 5.7% 20.6% 11.7% 56.3%
BV/TVOVX 2.9% 12.1% 6.7% 35.0%
D 22.8% 28.4% 25.0% 221.3%
D/BV/TVSHAM
(x100%)
249 241 243 238
Measurements acquired at six weeks after OVX (N= 5).
doi:10.1371/journal.pone.0000586.t001..
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or DAP12-/-FcRc-/- mice formed mononucleated TRACP+ cells
and failed to form multinucleated cells (Fig. 6C, 6G, 6K),
consistent with previous studies showing that high dose RANKL
could not rescue the multinucleation defect in DAP12-/- cells [4].
TGFb pre-treatment increased the formation of TRACP+ mono-
nuclear osteoclasts in DAP12-/- and DAP12-/-FcRc-/- cultures
approximately 2-fold compared to RANKL or TNFa (Fig. 6G,
6H, 6K and 6L). However, TGFb pre-treatment failed to rescue
the osteoclast multinucleation defect in DAP12-/- and DAP12-/-
FcRc-/- in vitro cultures (Fig. 6H, 6L). Thus, microenvironmental
cytokine changes induced by estrogen-deficiency including TGFb
and TNFa were unable to permit ITAM-adapter independent
osteoclastogenesis.
FSH fails to rescue the ITAM deficient osteoclast
defect
Recent reports suggest that increased FSH levels induced during
estrogen-deficiency play an important role in stimulating osteoclast
formation during postmenopausal osteoporosis [15]. FSH was
shown to stimulate RANKL induced osteoclastogenesis, including
increased multinucleation. To determine whether FSH could
potentiate osteoclast differentiation in ITAM-adapter deficient
mice, we evaluated the effect of FSH during in vitro osteoclastogen-
esis. BMM from WT, DAP12-/-, and DAP12-/-FcRc-/- were
cultured with 30 ng/ml FSH and 3 ng/ml RANKL for 3 days
followed by TRACP staining. FSH treatment alone failed to
induce any TRACP activity in BMM cultures independent of
ITAM-adapter status (Fig. 7Aa, Ad, Ag). Compared to RANKL
treatment alone, FSH and RANKL co-treatment increased
TRACP+ multinucleated osteoclast formation 3-fold in WT
cultures (Fig. 7Ac, 7B). Unlike WT cultures treated with FSH
and RANKL, there was no increase in the number of mono-
nuclear or multinuclear TRACP+ osteoclasts in DAP12-/- and
DAP12-/-FcRc-/- cultures. Additionally, FSH treatment alone or
in combination with RANKL failed to rescue the in vitro osteoclast
fusion defect in DAP12-/- and DAP12-/-FcRc-/- mice (Fig. 7Ae, f,
h, I; 7B). Whereas FSH synergistically increased WT osteoclas-
togenesis, we conclude that FSH was unable to drive ITAM-
adapter independent osteoclastogenesis.
Figure 4. Increased osteoclast formation in vivo in DAP12-/-FcRc-/- OVX group. (A) TRACP staining and DAPI staining was performed on paraffin
section of decalcified femur of SHAM and OVX groups of DKO mice. Brightfield and fluorescence images were taken with 406objective. Red staining
in brightfield indicates TRACP+cells. Magenta arrow indicates mononuclear TRACP+ osteoclasts; red asterisk indicates TRACP+ multinuclear osteoclasts
(MNCs). (B) Mononuclear, multinuclear, and total osteoclast number per section was counted. *: p,0.05; ***: p,0.001; when compared between
groups indicated by dotted line. N= 3 each group.
doi:10.1371/journal.pone.0000586.g004
Roles of ITAM Signaling in OVX
PLoS ONE | www.plosone.org 6 July 2007 | Issue 7 | e586
DISCUSSION
ITAM-mediated signaling has been shown to be critical for
osteoclast differentiation and function under normal physiological
conditions. ITAM signaling requires multiple components including
ITAM-containing adapter proteins, adapter-associated downstream
signal mediators, receptors, and their putative ligands. Variation in
the local expression any of these ITAM signaling components may
contribute to the changes in bone remodeling observed in unique
bone microenvironments. The deficiency of ITAM-containing
adapter proteins leads to a disconnection of intracellular signaling
from the osteoclast microenvironment sensed by the receptors
mediating these ITAM signals. Here we show that acute estrogen-
deficiency induced osteoporosis is differentially affected by de-
ficiency of ITAM adapter proteins. ITAM-adapter deficiency
(DAP12-/-FcRc-/-) leads to a complete blockade OVX induced
bone loss in vertebrae and cortical bones. However, quite
unexpectedly, ITAM signaling is bypassed in the estrogen-deficient
state with losses of significant amounts of trabecular bone in the
femur and tibia. More interesting, the mechanism bypassing ITAM
signaling was not readily explained by our current understanding of
requirements for osteoclastogenesis.
Severe osteopetrosis in the DAP12-/-FcRc-/- mice suggests that
ITAM-adapter signaling plays an important role in normal bone
remodeling. Unlike other severely osteopetrotic mice, such as those
deficient in MCSF-1 [16], PTHrP [17], c-fos [18], or RANKL
[19], DAP12-/-FcRc-/- mice have tooth eruption, suggesting that
there are mechanisms that allow normal osteoclastogenesis in the
absence of ITAM-adapter signals. Thus, even under normal
physiological conditions, distinct localized regulation of bone
remodeling in DAP12-/-FcRc-/- mice already exists. Signals that
can bypass the need for ITAM-adapter signaling to induce the
necessary osteoclast differentiation activity for tooth eruption are
not known. Severe osteopetrosis in the long bones in DAP12-/-
FcRc-/- mice suggests that during normal physiological conditions
osteoclastogenesis is largely controlled by ITAM-adapter signals
transduced through a ligand-receptor-adapter axis, presumably
involving interactions with the microenvironment. The exception
of tooth eruption and bone mobilization during estrogen-
deficiency suggests that there is an alternate signaling pathway
that can be elicited in specific sites during certain stresses to induce
bone remodeling.
Here we showed that during bone remodeling following acute
estrogen-deficiency, the defect of osteoclastogenesis and function
could be rescued in ITAM-adapter deficient mice in trabecular
long bone. Our data suggest that during a physiological state of
estrogen-deficiency, such as lactation, DAP12-/-FcRc-/- mice
Figure 5. OVX-induced osteoclast activity is not self-sustained in osteoclasts from DAP12-/- and DAP12-/-FcRc-/- mice. At six weeks post-OVX,
non-adherent bone marrow macrophages were cultured with 10 ng/mL M-CSF and 25 ng/mL RANKL on BD BioCoatTM OsteologicTM Bone Cell
Culture dishes. (A) Representative images of resorption pits where white represents pits and black in unresorbed substrate. Total resorption area (B)
and pit number (C) were calculated and shown. Standard error is shown. WT: wild-type mice; DKO: mice lacking both DAP12 and FcRc. N = 5 in each
group. Experiment was repeated three times. Representative images and results were shown.
doi:10.1371/journal.pone.0000586.g005
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would be able to mobilize calcium to nutritionally support bone
growth of the next generation. This emergency signaling pathway,
which is quiescent during normal physiological conditions,
activates osteoclasts and mobilizes mineral without utilizing
ITAM-adapter signaling. We applied different models and
theories to expand our understanding about how ITAM-adapter
signaling is bypassed during estrogen-deficiency in ITAM-adapter
deficient mice. Estrogen-deficiency can rescue the osteoclast defect
of ITAM-adapter deficient mice stimulating osteoclast multi-
nucleation and promoting bone resorption in vivo. However, unlike
wild-type mice, this enhanced osteoclastogenesis was not intrinsic
to BMMs or preosteoclasts in ITAM-adapter deficient mice, as
shown in the in vitro cultures. Secondly, estrogen-deficiency induces
changes in cytokine and hormone levels, including increased levels
of TNFa and FSH. Both TNFa and FSH have been shown to
stimulate or even substitute for RANKL during osteoclastogenesis
through different mechanisms. TNFa, in combination with TGFb,
can induce osteoclast differentiation and multinucleation in the
absence of RANKL in normal osteoclasts derived in vitro [12].
Increasing levels of FSH can cooperate with RANKL to have
a synergistic effect on osteoclast differentiation during estrogen-
deficiency in vitro [15]. However, as shown in this study, these two
new models could not explain the increase in multinucleated
osteoclasts seen in the DAP12-/-FcRc-/- OVX mice.
Although we investigated alternative methods of osteoclast
activation, one important mechanism that we did not address is
the role of T lymphocytes in acute estrogen-deficiency induced
bone loss. However, Pierre Jurdic and colleagues (Lyons, France)
have recently investigated the role of mature lymphocytes and
ITAM-adapter signaling in bone remodeling induced by OVX (A.
Anginot, et. al., PLoS One, in press). They have completed similar
studies examining the role of DAP12 signaling and mature T and
B cells in the acute estrogen deficient state in constitutively inactive
DAP12 (KD75), RAG1 (RAG1-/-), or double deficient (RAG1-/-;
KD75) mice. Their results demonstrate increased bone loss in the
double deficient (RAG1-/-; KD75) mice suggesting that DAP12
ITAM signals negatively regulate bone remodeling in RAG1-/-
mice consistent with our observations. Furthermore, RAG1-/- and
RAG1-/-;KD75 mice lose significant bone after OVX indicating
that mature T and B cells are not needed for estrogen-deficiency
induced bone loss and do not provide the missing signal for
osteoclastogenesis. Combined with our own studies, these results
strongly suggest a novel, still to be discovered, osteoclast activation
mechanism in vivo.
The complexity of the different roles of ITAM-adapter signaling
in different local microenvironments is consistent with the nature
of the associated receptors. TREM2 and OSCAR are immuno-
globulin superfamily innate immune receptors expressed on
osteoclasts. TREM2, associated with DAP12, is considered
a putative pattern-recognition receptor (PRR) because it recog-
nizes a wide variety of anionic ligands, including dextran sulfate
and bacterial products such as lipoteichoic acid and peptidoglycan
[20]. PRRs are genetically coded and able to recognize conserved
structural features in a large range of pathogens. Being able to
sense these environmental changes, PRRs could respond upon
ligand binding as a first line of defense. Presently, specific ligands
in the bone for these two receptors are still unidentified.
Recent findings convincingly show that ITAM-containing
adapter-receptor protein complexes can also send inhibitory
signals, although the mechanism is still unclear [21,22]. Despite
the general concept that the ITAM in the intracellular domain of
DAP12 will transduce an activation signal upon ligand binding of
the associated receptor, it has been shown by multiple groups that
DAP12-deficient macrophages have an enhanced response to
TLR stimulation [22]. It has also been shown that TREM2, but
not other DAP12-associated receptors, is responsible for trans-
ducing the inhibitory signal [23] [24]. It has been suggested that
the type of downstream signals induced (activating or inhibitory) is
dependent on the affinity and avidity of the extracellular ligands.
High affinity or avidity ligands have been proposed to initiate
activation, whereas low affinity or avidity ligands may cause
inhibition [21].
We have observed evidence of a dual function of ITAM-adapter
signaling in osteoclasts. The absence of downstream activation
Figure 6. RANKL-independent osteoclast differentiation induced by TGFb and TNF-a cytokines. BMMs from WT, DAP12-/- and DAP12-/-FcRc-/-
were separated and non-adherent preosteoclasts were cultured with RANKL (A, E, I); or pretreated by 2 ng/ml TGFb (B, F, J) for 2 days, followed by
30 ng/ml TNF-a treatment (C, G, K) or 25 ng/ml RANKL (D, H, L) for another 2 day. TRACP staining was performed at the end of the experiment, as
described. TRACP staining is indicated by dark purple. WT: wild-type mice; DKO: mice lacking both DAP12 and FcRc. Experiment was repeated three
times with representative results shown.
doi:10.1371/journal.pone.0000586.g006
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signal in ITAM-adapter deficient mice accounts for the osteope-
trosis and defective osteoclastogenesis in ITAM-adapter deficient
mice during normal physiological conditions. In our study,
DAP12-/-FcRc-/- mice lose about 40% trabecular long bone
following OVX, which is similar to wild type, DAP12-/-, and
FcRc-/- mice. However DAP12-/-FcRc-/- and DAP12-/- mice
have much higher baseline bone mass. If the absolute bone loss is
taken into consideration, DAP12-/-FcRc-/- mice and DAP12-/-
quantitatively lose more bone compared to wild-type mice. One
possible explanation is that a low affinity ligand in the bone
marrow compartment is engaged by TREM2/DAP12 that
initiates an inhibitory signal in osteoclasts through DAP12 to
fine-tune the resorption magnitude. In the absence of both ITAM-
adapter proteins, the ‘‘inhibitory’’ signals cannot be used to
regulate bone resorption, which leads to an extremely high
absolute trabecular bone loss in DAP12-/-FcRc-/- and DAP12-/-
OVX mice. Thus, ITAM signaling adapters may have multiple
functions in the regulation of osteoclasts. It will be necessary to
identify these putative ligands in the bone to gain further insight
into signals regulating these responses to local microenvironmental
changes at distinct location and different stimuli in bone
remodeling.
MATERIALS AND METHODS
Mice
All animal procedures were performed in accordance with
American Association for the Accreditation of laboratory Animals
Figure 7. Stimulatory effect of FSH has no effect on DAP12-deficient osteoclastogenesis. BMMs from WT, DAP12-/-, and DAP12-/-FcRc-/- were
separated and non-adherent BMMs were cultured with 30 ng/ml FSH alone (Aa, Ad, Ag), 3 ng/ml RANKL alone (Ab, Ae, Ah), or FSH and RANKL (Ac, Af,
Ai) for 4 days. TRACP staining was performed at the end of the experiment, as described. Dark purple staining indicates that cells are TRACP positive.
The number of multinucleated (.3nuclei) -osteoclasts were calculated and shown in (B). DKO: mice lacking of both DAP12 and FcRc. Experiment was
repeated three times with representative results shown.
doi:10.1371/journal.pone.0000586.g007
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(AAALC) guidelines and were approved by the VA Animal Care
Committee. Mice were maintained under sterile conditions. WT,
DAP12-/-, FcRc-/- and DAP12-/-FcRc-/-mice were on a C57BL/
6 background. C57BL/6 and FcRc-/- was purchased from Jackson
Laboratory (Bar Harbor, ME). DAP12-/- mice were kindly
provided by Dr. Lewis L. Lanier (University of California at San
Francisco). DAP12-/-FcRc-/- mice were kindly provided Dr. Cliff
Lowell (University of California at San Francisco). Female mice
around 8–12 weeks of age were either subjected to sham or
bilateral ovariectomy operation. Blood and urine sample was
collected at 4 weeks post operation. At 6 weeks post operation,
mice were sacrificed. Femur, tibia and lumbar vertebrate were
excised for histology and micro-computed tomography analysis.
Bone marrow was harvested for in vitro culture analysis. Uterine
weight was determined to verify uterine atrophy.
Bone turnover marker measurement
Blood and urine samples were collected 4 weeks post operation.
Serum osteocalcin, a bone formation marker, was measured by
mouse osteocalcin ELISA kit (Biomedical Technologies, Inc.,
Stoughton, MA) according to manufacture’s protocol. Urine
deoxypyridinoline, a bone resorption marker, was measured by
METRAH DPD (Quidel Corp., San Diego, CA) according to
manufacture’s protocol. Amount of urine DPD was standardized
with creatinine using METRAH creatinine kit (Quidel Corp., San
Diego, CA).
Micro-Computed Tomography (CT) Analysis
As previously described [4,25], proximal tibias and distal femurs
were scanned at the end of the experiment. Briefly, after being
fixed serially in 4% formaldehyde and 70% ethanol, the proximal
tibias and distal femurs were scanned by high resolution Scanco
vivaCT 40 mCT scanner (Scanco Medical, Bassersdorf, Switzer-
land) with a resolution size of 10.5 mm. For proximal tibia and
distal femur, scanning was initiated proximal to growth plate, and
a total of 120 consecutive 10.5-mm-thick sections were analyzed.
Cortical bone was excluded from the region of interest. The
segmentation values were set constantly at 0.7/1/250. Cortical
bone analysis was done at the tibia proximal to tibiofibular
junction with a total of 60 consecutive 21-mm-thick sections.
Stromal cavity was excluded from the region of interest with 30
slices evaluated. The segmentation values were set at 0.7/1/250.
Three-dimensional reconstruction and structural parameters
quantification were calculated using Scanco Medical software.
BMMs culture and osteoclastogenesis
Bone marrow monocyte/macrophage (BMM) precursor cells were
flushed out from femurs and tibias by 25-G needle. Cells were
washed by PBS and lysed with RBC lysis buffer (0.16 M NH4Cl,
0.17 M Tris; pH 7.65) for 5 minutes at room temperature, and
washed by PBS. Cells were cultured in complete a-MEM
(Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal
bovine serum, 1% glutamine Pen-Strep, and 10–20 ng/ml M-CSF
(Sigma-Aldrich, St. Louis, MO). After 2 days in culture with M-
CSF, non-adherent BMMs were transferred to a new plate at
a density of 100,000 cells/well in 96-well plate or 250,000 cells/
well in 24-well plate. BMMs were cultured in complete a-MEM
with 25 ng/ml RANKL (PeproTech, Rocky Hill, NJ) with 10 ng/
ml M-CSF for an additional 3–5 days, with fresh media every
3 days.
TRACP staining
After 3–5 days in culture, cells were fixed in 4% formaldehyde in
PBS for 10 minutes. Plates were washed with PBS, incubated with
0.05% Triton X-100 in PBS for 10 minutes at room temperature.
Cells were stained for TRACP using a commercial kit (product
387-A; Sigma-Aldrich, St. Louis, MO) according to manufacture’s
protocol. Multinucleated (.2 nuclei) TRACP+ cells were counted
and scored under microscopy.
Histology staining
Six weeks post-operation, femurs were dissected and fixed with 4%
formaldehyde for 12 hours at room temperature. Femurs were
decalcified at 4uC for 1 week by decalcification buffer (10%
EDTA [w/w] in 16 PBS), which was changed every other day.
The bone samples were then processed and mounted in paraffin
and sectioned into 5 mm thickness. TRACP staining was
performed as described above. Methyl Green and DAPI
(Invitrogen, Carlsbad, CA) were used for nuclear counterstaining
for bright-field and fluorescence imaging. To create the overlay
image, the DAPI fluorescent image was pasted on top of the
bright-field image as a layer in Adobe Photoshop CS2 (Adobe
Systems, Inc., San Jose, CA). By choosing ‘‘Difference’’ as the
‘‘Blend Mode’’ option, two layers were flattened to yield the
overlay image.
BD BioCoat assay
Bone marrow macrophages were harvested as described above.
Macrophages were plated on BD BioCoat Osteologic Discs (BD
Biosciences) at density of 100,000 cells/well and were treated with
RANKL 25 ng/ml and M-CSF 10 ng/ml for 5–10 days. Media
were changed every 3 days. BD BioCoat discs were treated with
20% bleach and agitated for 5 minutes to remove adherent cells,
followed by 5 washes with dH2O and air-dried. The surface area
with active bone resorption was visualized under Olympus
microscope BX51 and measured by using BioQuant OSTEO II
software (BioQuant Image Analysis Corporation, Nashville, TN).
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